Related Experiment Video
Updated: Aug 19, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Membranous glomerulonephritis in patients with rheumatoid arthritis
A Yoshida1, K Morozumi, A Takeda
1Division of Nephrology, Nagoya Daini Red Cross Hospital, Japan.
Abstract:
We investigated the cause of membranous glomerulonephritis (MGN) in 24 patients with rheumatoid arthritis (RA). The class or stage of RA was diagnosed using the criteria of the American Rheumatism Association, and MGN was diagnosed using renal biopsy. Renal biopsy and laboratory findings, including serologic analysis, were evaluated. Eighteen patients had previously received one of the following antirheumatic agents: bucillamine (n = 13), D-penicillamine (n = 3), or gold (n = 2). The renal lesions of all 24 patients resembled lesions seen with idiopathic MGN on examination by light microscopy, electron microscopy, and immunofluorescence. We concluded that patients with RA are predisposed to develop MGN, whether or not they receive antirheumatic agents.
Insights
Rheumatoid arthritis (RA) patients have an increased risk of developing membranous glomerulonephritis (MGN). This kidney condition can occur regardless of whether patients are treated with antirheumatic drugs.
Area of Science:
- Nephrology
- Rheumatology
- Pathology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Membranous glomerulonephritis (MGN) is a common cause of nephrotic syndrome in adults.
Purpose of the Study:
- To investigate the association between rheumatoid arthritis and membranous glomerulonephritis.
- To determine if antirheumatic agents influence the development of MGN in RA patients.
Main Methods:
- Retrospective analysis of 24 RA patients diagnosed with MGN via renal biopsy.
- Evaluation of renal biopsy findings (light microscopy, electron microscopy, immunofluorescence).
- Review of patient laboratory data and medical history, including antirheumatic drug use.
Main Results:
- All 24 RA patients exhibited renal lesions consistent with idiopathic MGN.
- Eighteen patients had prior exposure to antirheumatic agents (bucillamine, D-penicillamine, gold).
- No specific link was established between antirheumatic drug use and MGN development.
Conclusions:
- Patients with rheumatoid arthritis have a predisposition to develop membranous glomerulonephritis.
- MGN in RA patients can occur independently of treatment with antirheumatic medications.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease I: Introduction
Diabetic Nephropathy

